Correlation Between HCW Biologics and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Spero Therapeutics, you can compare the effects of market volatilities on HCW Biologics and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Spero Therapeutics.
Diversification Opportunities for HCW Biologics and Spero Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HCW and Spero is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Spero Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and Spero Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to generate 21.93 times more return on investment than Spero Therapeutics. However, HCW Biologics is 21.93 times more volatile than Spero Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.2 per unit of risk. If you would invest 44.00 in HCW Biologics on August 30, 2024 and sell it today you would earn a total of 6.00 from holding HCW Biologics or generate 13.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
HCW Biologics vs. Spero Therapeutics
Performance |
| Timeline |
| HCW Biologics |
| Spero Therapeutics |
HCW Biologics and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Spero Therapeutics
The main advantage of trading using opposite HCW Biologics and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |